BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9156519)

  • 1. Monoclonal antibodies to the human TSH receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cells.
    Nicholson LB; Vlase H; Graves P; Nilsson M; Molne J; Huang GC; Morgenthaler NG; Davies TF; McGregor AM; Banga JP
    J Mol Endocrinol; 1996 Apr; 16(2):159-70. PubMed ID: 9156519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of monoclonal antibodies to the human thyrotropin (TSH) receptor: antibodies can bind to discrete conformational or linear epitopes and block TSH binding.
    Seetharamaiah GS; Wagle NM; Morris JC; Prabhakar BS
    Endocrinology; 1995 Jul; 136(7):2817-24. PubMed ID: 7540542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of monoclonal antibodies specific for the murine thyrotropin receptor.
    Davies TF; Bobovnikova Y; Weiss M; Vlase H; Moran T; Graves PN
    Thyroid; 1998 Aug; 8(8):693-701. PubMed ID: 9737366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an important thyrotrophin binding site on the human thyrotrophin receptor using monoclonal antibodies.
    Shepherd PS; Da Costa CR; Cridland JC; Gilmore KS; Johnstone AP
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):197-206. PubMed ID: 10375031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.
    Van Der Heijden JH; De Bruin TW; Glaudemans KA; De Kruif J; Banga JP; Logtenberg T
    Clin Exp Immunol; 1999 Nov; 118(2):205-12. PubMed ID: 10540180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies.
    Oda Y; Sanders J; Evans M; Kiddie A; Munkley A; James C; Richards T; Wills J; Furmaniak J; Smith BR
    Thyroid; 2000 Dec; 10(12):1051-9. PubMed ID: 11201849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of the antibody response to the extracellular region of recombinant thyrotropin receptor.
    Morgenthaler NG; Kim MR; Gardas A; Vlase H; Aust G; Gupta M; McGregor AM; Banga JP
    Autoimmunity; 1997; 26(2):75-84. PubMed ID: 9546816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.
    Carayanniotis G; Huang GC; Nicholson LB; Scott T; Allain P; McGregor AM; Banga JP
    Clin Exp Immunol; 1995 Feb; 99(2):294-302. PubMed ID: 7851025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thyrotrophin hormone receptor of Graves' disease: overexpression of the extracellular domain in insect cells using recombinant baculovirus, immunoaffinity purification and analysis of autoantibody binding.
    Huang GC; Page MJ; Nicholson LB; Collison KS; McGregor AM; Banga JP
    J Mol Endocrinol; 1993 Apr; 10(2):127-42. PubMed ID: 8484862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
    Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
    Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
    Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
    Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of monoclonal antibodies to the human thyrotropin receptor.
    Marion S; Ropars A; Ludgate M; Braun JM; Charreire J
    Endocrinology; 1992 Feb; 130(2):967-75. PubMed ID: 1733738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.
    Sanders J; Bolton J; Sanders P; Jeffreys J; Nakatake N; Richards T; Evans M; Kiddie A; Summerhayes S; Roberts E; Miguel RN; Furmaniak J; Smith BR
    Thyroid; 2006 Dec; 16(12):1195-206. PubMed ID: 17199429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folding of the recombinant human thyrotropin (TSH) receptor extracellular domain: identification of folded monomeric and tetrameric complexes that bind TSH receptor autoantibodies.
    Graves PN; Vlase H; Davies TF
    Endocrinology; 1995 Feb; 136(2):521-7. PubMed ID: 7530646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
    Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
    Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL; Erlanger BF
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies.
    Morgenthaler NG; Tremble J; Huang G; Scherbaum WA; McGregor AM; Banga JP
    J Clin Endocrinol Metab; 1996 Feb; 81(2):700-6. PubMed ID: 8636291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.